|
May 14
|
The Strong Earnings Posted By Catalyst Pharmaceuticals (NASDAQ:CPRX) Are A Good Indication Of The Strength Of The Business
|
|
May 1
|
Will Xencor (XNCR) Report Negative Q1 Earnings? What You Should Know
|
|
Apr 30
|
Catalyst Pharmaceutical (CPRX) Earnings Expected to Grow: Should You Buy?
|
|
Apr 30
|
Is Now The Time To Put Catalyst Pharmaceuticals (NASDAQ:CPRX) On Your Watchlist?
|
|
Apr 30
|
Catalyst Pharmaceuticals to Participate in the BofA Securities Health Care Conference 2025
|
|
Apr 27
|
Catalyst Pharmaceuticals, Inc. (CPRX): Among Stocks with Consistent Growth to Buy Now
|
|
Mar 14
|
Is Catalyst Pharmaceuticals, Inc. (CPRX) the Best Healthcare Stock For Long-Term Investment?
|
|
Feb 28
|
Catalyst Pharmaceuticals Full Year 2024 Earnings: Beats Expectations
|
|
Feb 28
|
Catalyst Pharmaceuticals Inc (CPRX) Q4 2024 Earnings Call Highlights: Record Revenue Growth and ...
|
|
Feb 27
|
Here's What's Driving Catalyst Pharmaceuticals Stock 8% Higher Today
|
|
Feb 27
|
Catalyst (CPRX) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
|
|
Feb 26
|
Catalyst Pharmaceutical (CPRX) Tops Q4 Earnings and Revenue Estimates
|
|
Feb 26
|
Catalyst: Q4 Earnings Snapshot
|
|
Feb 26
|
Catalyst Pharmaceuticals Reports Record Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
|
|
Jan 3
|
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
|